Advances in antiplatelet therapy: agents in clinical development.
about
Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomicsPharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases.Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome.The SCHOOL of nature: III. From mechanistic understanding to novel therapiesPerioperative management of patients on chronic antithrombotic therapyPlatelet P2Y12 receptor inhibition by thienopyridines: status and future.Cangrelor: a review on its mechanism of action and clinical development.Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonist.Update on the clinical development of cangrelor.Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS?Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome.Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives.Advances in platelet function testing assessing bleeding complications in patients with coronary artery disease.Antiplatelet and anticoagulant therapy for atherothrombotic disease: the role of current and emerging agents.Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.Pharmacology of antiplatelet agents.An anti-von Willebrand factor aptamer reduces platelet adhesion among patients receiving aspirin and clopidogrel in an ex vivo shear-induced arterial thrombosis.Antiplatelet Management for Coronary Heart Disease: Advances and Challenges.Overcoming limitations of current antiplatelet drugs: a concerted effort for more profitable strategies of intervention.A Comparative Study of Molecular Structure, pKa, Lipophilicity, Solubility, Absorption and Polar Surface Area of Some Antiplatelet Drugs.ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome
P2860
Q26822796-AC1C7ED1-2A13-4F9B-BD44-35B2A26B582BQ33685876-01384B1C-0BB5-49B3-A387-760F4BBDF3BAQ34129340-4032EF8B-DB2D-4E60-8248-8198182268F3Q34619705-E34A8AF6-A043-4D24-B008-25A8DF0B38E1Q36842832-36B43BE8-9CD6-41DE-84CB-C6CC90320D54Q37579228-1FE58AC9-8980-42D1-B34B-91011D0B9BE3Q37611039-70AA41EB-A4B4-441D-823C-B30EFAFFC2C3Q37688144-A5BB51CC-A1DE-41F0-9441-C3AC4FA1EEFDQ37776511-6A45BD43-DF78-4DBE-ADB0-AD11707317FFQ37878982-D4636F2B-4F3A-4041-8D93-07085D1D9658Q37990848-597D07E5-B6E1-4820-9FA6-41A97A49537BQ38018679-05B2A828-762A-4477-BD49-D2E05E0A5118Q38027576-B6129521-567A-4EBC-AC8A-F5FD1029D1B9Q38101275-95F423D9-36AC-48CD-A17A-0DC51F59603EQ38151563-64800DCC-030D-4D5F-9319-C1F6B849EDECQ38154211-6454B3BB-04BD-4404-9F9B-BE6C179FC1C1Q38339355-9DF4D4BD-D231-49D0-A335-AB30E85C24C0Q38824035-1082CBD5-955C-46F3-BDFD-528E44481D52Q39635786-B9C239E9-D09E-4306-B6DE-5224561CBC78Q39671290-357C3108-4AD4-4D00-976B-3599C0E73AB6Q57764209-FEBA648E-77A6-4A5B-8682-E7D372149031
P2860
Advances in antiplatelet therapy: agents in clinical development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in antiplatelet therapy: agents in clinical development.
@en
Advances in antiplatelet therapy: agents in clinical development.
@nl
type
label
Advances in antiplatelet therapy: agents in clinical development.
@en
Advances in antiplatelet therapy: agents in clinical development.
@nl
prefLabel
Advances in antiplatelet therapy: agents in clinical development.
@en
Advances in antiplatelet therapy: agents in clinical development.
@nl
P2093
P1476
Advances in antiplatelet therapy: agents in clinical development.
@en
P2093
Deepak L Bhatt
Dominick J Angiolillo
Lisa K Jennings
Paul A Gurbel
P304
P356
10.1016/J.AMJCARD.2008.11.023
P407
P433
P577
2009-02-01T00:00:00Z